Pharma Investor Relations Networking
How Pharma professionals use digital business cards for investor relations networking
Discover how pharma professionals are transforming their approach to investor relations networking with NexaLink digital business cards. This step-by-step guide shows you exactly how to prepare, execute, and follow up to maximize every connection.
The Challenge
You need to build and maintain relationships with investors, analysts, and financial advisors focused on the pharma sector. Each contact has different interests, investment theses, and communication preferences.
Step-by-Step Guide
Build an IR-Focused Card
Create a NexaLink card specifically for investor relations that highlights your pharma company's key metrics, investor deck, and IR contact information.
Tip: Link to your latest quarterly report or investor presentation.
Share at Investor Conferences
At pharma investor conferences and roadshows, share your IR card with analysts and fund managers. This gives them instant access to your investor materials.
Segment Your Investor Network
Tag investors by type (VC, PE, angel, analyst), pharma focus area, check size, and relationship stage in NexaLink CRM.
Tip: Track each investor's portfolio companies to understand their investment thesis.
Maintain Regular Touchpoints
Use your tagged investor database to send quarterly pharma updates, milestone announcements, and personalized outreach at appropriate intervals.
Tools You Need
Pro Tips
- ★Update your IR card before every pharma investor event with the latest metrics.
- ★Track which investors viewed your card to gauge interest levels.
- ★Include a calendar link on your card for easy meeting scheduling.
- ★Send pharma industry insights between funding rounds to stay top of mind.
- ★Build relationships with analysts who cover your sector for long-term visibility.
Expected Results
Build a curated database of 50-100 pharma investors and analysts.
Reduce investor meeting scheduling friction by 70%.
Maintain consistent communication with your investor network.
Increase inbound investor interest through professional pharma IR presence.
NexaLink Features for This Use Case
Designs for every industry — minimal, bold, classic, and more
Generate a unique QR code anyone can scan to view your card
Tap phones together to exchange cards (Pro)
Save your card to mobile wallets for one-tap access
See views, clicks, and engagement trends over time
Match your brand with custom colors, logo, and fonts
Add LinkedIn, X, Instagram, website, and more
Recipients save your info to their phone in a single tap
Frequently Asked Questions
How do I use NexaLink for investor relations?
Create an IR-focused card with your latest pharma metrics, pitch deck, and scheduling link. Share it at conferences, roadshows, and one-on-one meetings for instant access to investor materials.
Can I track investor engagement with my card?
Yes. NexaLink shows you who viewed your card and how frequently. This helps you identify your most engaged investors and prioritize follow-ups.
How do I segment different types of investors?
Use NexaLink CRM tags to categorize investors by type, focus area, check size, and relationship stage. This enables targeted, relevant communication.
Do recipients need the NexaLink app?
No. When someone scans your QR code, taps your NFC, or clicks your link, your card opens as a mobile-optimized webpage in their browser. They can save your contact directly — no download required.
Can I update my card after sharing it?
Yes. Change your job title, phone number, or company and every person who received your card sees the update instantly. No reprints, no re-sharing — one card, always current.
Is there a free plan?
Yes. The free plan includes 1 digital card, basic templates, QR code sharing, and 10 card scans per month — with no time limit or credit card required. Upgrade to Pro ($5.99/month) for unlimited cards and NFC sharing.
Get Started with NexaLink — Free
Create your digital card, scan business cards, and manage your network.
You Might Also Like
Explore related guides across different topics